U.S. stock futures rose on Monday, building on Friday’s gains. Optimism is fueled by New York Fed President John Williams‘ suggestion that a December rate cut remains possible.
The Dow Jones Industrial Average rose 0.44% to 46,448.27, the S&P 500 added 1.5% to 6,705.12, and the Nasdaq jumped 2.69% to 22,872.00.
These are the top stocks that gained the attention of retail traders and investors through the day:
Broadcom’s stock surged 11.10% to close at $377.96, reaching an intraday high of $382 and a low of $347.66. The stock’s 52-week high is $386.48, with a low of $138.10. In the after-hours trading, the stock rose 1.49% to $383.60.
The semiconductor sector saw a boost as hopes for a December Fed rate cut lifted tech stocks. Federal Reserve Governor Christopher Waller’s supportive comments further fueled the rally.
Alphabet’s Class C shares climbed 6.28% to close at $318.47, with an intraday high of $319.80 and a low of $309.40. The stock hit a new 52-week high of $319.80, with a low of $142.66. The stock gained 2.65% in the after-hours trading to $326.90.
The company’s Class A shares ended the day 6.3% higher at $318.58. The Class A stock gained 2.6% to $327 in extended trading.
Alphabet was reported to be in talks with Meta and other cloud clients to supply Google's ( GOOG ) AI TPU chips, signaling an escalation in its competition with Nvidia. Alphabet shares jumped to new highs, up about 2% after-hours, while Nvidia slipped roughly 2%. Google's ( GOOG ) stock has surged about 52% since mid-September, boosted by a strong reception to its Gemini 3 AI release.
SanDisk’s stock rose 13.33% to $226.96, with a high of $228.18 and a low of $205.13. The stock’s 52-week high is $284.76, with a low of $27.90. The stock popped 7.29% to $243.50 in the after-hours trading.
Sandisk ( SNDK ) was added to the S&P 500, replacing Interpublic Group after its acquisition by Omnicom, with the change set for Nov. 28. PTC Therapeutics will replace Sandisk ( SNDK ) in the S&P SmallCap 600.
Sandisk ( SNDK ) had also reported strong fourth-quarter results on Nov. 6, beating revenue and EPS estimates for the eighth time in ten quarters.
Novo Nordisk ( NVO ) shares fell 5.58% to $44.97, with a high of $45.22 and a low of $43.08. The stock’s 52-week high is $112.52, with a low of $43.08. The shares rose 1.07% to $45.45 in extended trading.
Novo Nordisk ( NVO ) reported that its 2-year evoke and evoke+ trials, involving 3,808 adults with early Alzheimer's, did not show semaglutide to be superior to placebo in slowing disease progression based on CDR-SB scores. The drug improved biomarkers but failed to translate those changes into clinical benefit. The company will discontinue the 1-year extension phase, though semaglutide remained safe and well-tolerated in patients aged 55–85.
Zoom’s stock dipped slightly by 0.04% to close at $78.60 with an intraday high of $80.27 and a low of $78.59. The stock’s 52-week high is $92.80, with a low of $64.41. The stock popped 3.6% to $81.45 in the after-hours trading.
Zoom reported third-quarter revenue of $1.23 billion and adjusted earnings of $1.52 per share, beating forecasts of $1.21 billion and $1.44 per share, respectively, with enterprise revenue rising 6.1% year-over-year. The company ended the quarter with 4,363 large customers and generated $629.3 million in operating cash flow. Zoom also issued slightly higher fourth-quarter and full-year guidance, raising its fiscal 2026 revenue and earnings outlook.
Benzinga Edge Stock Rankings show that Google’s Class C shares have a Value in the 26th percentile. Here is how they compare against other Magnificent 7 stocks.
Prepare for the day’s trading with top premarket movers and news by Benzinga.
Read Next:
‘Big Short’-Fame Investor Steve Eisman Says ‘Good Time To Buy’ This ‘Pretty Inexpensive’ Insurance Stock: ‘You Will Make Money Over Time’
This story was generated using Benzinga Neuro and edited by Shivdeep Dhaliwal